Michael Burkes Brophy - 03 Feb 2026 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Tami Chen, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
03 Feb 2026
Net transactions value
-$1,580,926
Form type
4
Filing time
04 Feb 2026, 21:35:05 UTC
Previous filing
29 Jan 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brophy Michael Burkes CHIEF FINANCIAL OFFICER C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN /s/ Tami Chen, Attorney-in-Fact 04 Feb 2026 0001697362

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Sale $292,614 -1,268 -2.1% $230.77 57,791 03 Feb 2026 Direct F1
transaction NTRA Common Stock Sale $157,674 -700 -1.2% $225.25 57,091 03 Feb 2026 Direct F2, F3
transaction NTRA Common Stock Sale $1,130,639 -4,971 -8.7% $227.45 52,120 03 Feb 2026 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.98 to $225.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.69 to $227.68 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.